New intervention strategies for reducing antibiotic resistance

被引:63
作者
Yates, RR [1 ]
机构
[1] Tyler Hosp, Tyler, TX USA
关键词
antibiotic resistance; antibiotic susceptibility; extended-spectrum penicillins; nosocomial infections;
D O I
10.1378/chest.115.suppl_1.24S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rising antibiotic resistance rates among bacterial pathogens have resulted in increased morbidity and mortality from nosocomial infections. Widespread use of certain antibiotics, particularly third-generation cephalosporins, has been shown to foster development of generalized beta-lactam resistance in previously susceptible bacterial populations, Reduction in the use of these agents (as well as imipenem and vancomycin) and concomitant increases in the use of extended-spectrum penicillins and combination therapy with aminoglycosides have been shown to restore bacterial susceptibility, Studies have shown that education-based methods, as opposed to coercive measures, are effective in changing the prescribing habits of physicians. Cooperative interaction among infectious-disease physicians, clinical pharmacists, microbiology-laboratory personnel, and infection-control specialists is essential to provide useful suggestions regarding antibiotic choice and dosing to the prescribing physician in real time. Several hospitals have implemented antimicrobial resistance management programs based on these findings. The results of these programs validate the use of a multidisciplinary, education-based, antibiotic-resistance management approach.
引用
收藏
页码:24S / 27S
页数:4
相关论文
共 21 条
  • [1] BALLOW CH, 1992, DIAGN MICR INFEC DIS, V15, pS37
  • [2] Antibiotic resistance - Squeezing the balloon?
    Burke, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14): : 1270 - 1271
  • [3] Hospital-wide restriction of clindamycin:: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
    Climo, MW
    Israel, DS
    Wong, ES
    Williams, D
    Coudron, P
    Markowitz, SM
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) : 989 - +
  • [4] CLINICAL CONSEQUENCES OF DEVELOPMENT OF RESISTANCE TO 3RD GENERATION CEPHALOSPORINS
    FOLLATH, F
    COSTA, E
    THOMMEN, A
    FREI, R
    BURDESKA, A
    MEYER, J
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) : 446 - 450
  • [5] Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership
    Goldmann, DA
    Weinstein, RA
    Wenzel, RP
    Tablan, OC
    Duma, RJ
    Gaynes, RP
    Schlosser, J
    Martone, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03): : 234 - 240
  • [6] CHANGING PHYSICIANS PRACTICES
    GRECO, PJ
    EISENBERG, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (17) : 1271 - 1274
  • [7] MORE EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1697 - 1704
  • [9] JONES RN, 1992, DIAGN MICR INFEC DIS, V15, pS3
  • [10] JOSHI M, IN PRESS J ANTIMICRO